Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • News
Posted on January 5, 2023

AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance

AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma  Yahoo Finance
Source: AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance

By sf-admin

Post navigation

DiaCarta Announces Successful Completion of Oncuria® Validation … – GlobeNewswire
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease … – Yahoo Finance


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace